Director/PDMR Shareholding
4basebio PLC announced that its Chief Executive Officer, Dr. Amy Walker, purchased 1,863 ordinary shares on the market for 509.00 pence per share on May 21, 2026. This transaction increases her shareholding to 48,529 ordinary shares, representing 0.31% of the Company's issued share capital, which comprises 15,538,518 ordinary shares. The purchase of these shares, representing approximately 0.01% of the issued share capital, indicates confidence from the CEO in the company's prospects.
Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes
4basebio PLC (AIM: 4BB), a company pioneering an enzymatically-produced DNA technology serving the next generation genetic medicines markets, announces that on 21 May 2026 it was informed that Dr. Amy Walker, Chief Executive Officer of the Company, purchased 1,863 ordinary shares in the capital of the Company through the market.
Further details are set out in the Notification of Dealing Form below.
| Director / PCA | Number of ordinary shares urchased | Purchase price (pence) | Shareholding following purchase | Shareholding following purchase as a % of the issued share capital |
|---|---|---|---|---|
| Dr. Amy Walker | 1,863 | 509.00 | 48,529 | 0.31% |
The 1,863 shares purchased represent approximately 0.01 per cent. of the Company's issued share capital.
The issued share capital of the Company comprises 15,538,518 ordinary shares.
.
| 1 | Details of the persons discharging managerial responsibilities / person closely associated | |
| a) | Name | Dr. Amy Walker |
| 2 | Reason for the notification | |
| a) | Position/Status | Chief Executive Officer |
| b) | Initial notification/ Amendment | Initial notification |
| a) | Name | 4basebio plc |
| b) | LEI | 213800E2DX9EAIUNCB30 |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares ISIN: GB00BMCLYF79 |
| b) | Nature of the transaction | Acquisition of ordinary shares |
| c) | Price(s) and volume(s) | Price: 509.00p Volume: 1,863 |
| d) | Aggregated information - Aggregated volume - Aggregated Price | See above |
| e) | Date of transaction | 21 May 2026 |
| f) | Place of transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.